Diligence memo · auto-generated · as of July 2, 2026

Springfield Florissant Resources LLC

Springfield Florissant Resources LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Springfield Florissant Resources LLC operates in Other Health Care, based in CEDARHURST.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Springfield Florissant Resources LLC has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.6M on 2018-08-07.

Most recent recorded round closed around 2018-08-07.

Valuation (modeled)modeled

Provath models Springfield Florissant Resources LLC at approximately $41M (range $1.4M–$321M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.92× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era. Within the normal band (92% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 7.9 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 44% of Other Health Care peers (5377 compared).

Modeled value ranks above 64% of those peers.

Closest niche peers: Eye Academy of America Ltd., Ruddco Inc., Guest House Holdings, LLC, Cb Therapeutics Inc., Shift Sciences, LLC.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.